Recent advances in hypoxia-inducible factor (HIF)-1 inhibitorsYAN XIA; CHOI, Hyun-Kyung; LEE, Kyeong et al.European journal of medicinal chemistry. 2012, Vol 49, pp 24-40, issn 0223-5234, 17 p.Article

Synthesis and biological evaluation of new homocamptothecin analogsYU LUO; SHANBAO YU; LINJIANG TONG et al.European journal of medicinal chemistry. 2012, Vol 54, pp 281-286, issn 0223-5234, 6 p.Article

Utility of 4-(5,5-Dimethyl-3-oxo-cyclohex-1-enylamino)benzenesulfonamide in the Synthesis of Novel Quinolines as Possible Anticancer and Radioprotective AgentsGHORAB, Mostafa M; RAGAB, Fatma A; NOAMAN, Eman et al.Arzneimittel-Forschung. 2008, Vol 58, Num 1, pp 35-41, issn 0004-4172, 7 p.Article

Chemoembolization of Tongue Carcinoma with Ethylcellulose Microcapsuled Carboplatinum and its Basic StudyHONG HE; FEIYUN PING; GUANFU CHEN et al.Artificial cells, blood substitutes, and biotechnology. 2008, Vol 36, Num 2, pp 114-122, 9 p.Article

Redox activation of metal-based prodrugs as a strategy for drug deliveryGRAF, Nora; LIPPARD, Stephen J.Advanced drug delivery reviews. 2012, Vol 64, Num 11, pp 993-1004, issn 0169-409X, 12 p.Article

A Uniform Procedure for Reimbursing the Off-Label Use of Antineoplastic Drugs According to the Value-for-Money ApproachMESSORI, A; FADDA, V; TRIPPOLI, S et al.Journal of chemotherapy (Testo stampato). 2011, Vol 23, Num 2, pp 67-70, issn 1120-009X, 4 p.Article

Electrochemical approach of anticancer drugs-DNA interactionRAUF, S; GOODING, J. J; AKHTAR, K et al.Journal of pharmaceutical and biomedical analysis. 2005, Vol 37, Num 2, pp 205-217, issn 0731-7085, 13 p.Article

Haematological anticancer drugs in Europe : any added value at the time of approval?BERTELE, Vittorio; BANZI, Rita; CAPASSO, Filippo et al.European journal of clinical pharmacology. 2007, Vol 63, Num 7, pp 713-719, issn 0031-6970, 7 p.Article

Sensitization for anticancer drug-induced apoptosis by the chemopreventive agent resveratrolFULDA, Simone; DEBATIN, Klaus-Michael.Oncogene (Basingstoke). 2004, Vol 23, Num 40, pp 6702-6711, issn 0950-9232, 10 p.Article

Drug Interactions Between Chemotherapeutic Regimens and AntiepilepticsYAP, Kevin Yi-Lwern; WAI KEUNG CHUT; CHAN, Alexandre et al.Clinical therapeutics. 2008, Vol 30, Num 8, pp 1385-1407, issn 0149-2918, 23 p.Article

A novel micelle-encapsulated platinum(II) anticancer agentJADHAV, Vithal B; YONG JOO JUN; JU HEE SONG et al.Journal of controlled release. 2010, Vol 147, Num 1, pp 144-150, issn 0168-3659, 7 p.Article

Effect of Extremely Low-Frequency (ELF) Magnetic Fields on the Potency of Drugs in Bacterial CellsKAKIKAWA, Makiko; IMAI, Shunsuke; YAMADA, Sotoshi et al.IEEE transactions on magnetics. 2014, Vol 50, Num 4, issn 0018-9464, 5000104.1-5000104.4, 2Article

Polymeric nanofibers as novel carriers for the delivery of therapeutic moleculesKUMBAR, Sangamesh G; NAIR, Lakshmi S; BHATTACHARYYA, Subhabrata et al.Journal of nanoscience and nanotechnology (Print). 2006, Vol 6, Num 9-10, pp 2591-2607, issn 1533-4880, 17 p.Article

Lead optimization through VLAK protocol: New annelated pyrrolo-pyrimidine derivatives as antitumor agentsLAURIA, Antonino; PATELLA, Chiara; ABBATE, Ilenia et al.European journal of medicinal chemistry. 2012, Vol 55, pp 375-383, issn 0223-5234, 9 p.Article

Consensus-Based Evaluation of Clinical Significance and Management of Anticancer Drug InteractionsJANSMAN, Frank G. A; REYNERS, An K. L; KERREMANS, Adrian L et al.Clinical therapeutics. 2011, Vol 33, Num 3, pp 305-314, issn 0149-2918, 10 p.Article

Anticancer drugs loading into and in vitro release from faujasiteBETSIOU, M; BANTSIS, G; ZOI, I et al.Clay minerals. 2011, Vol 46, Num 4, pp 613-619, issn 0009-8558, 7 p.Article

IK1 channel activity contributes to cisplatin sensitivity of human epidermoid cancer cellsLEE, Elbert L; HASEGAWA, Yuichi; SHIMIZU, Takahiro et al.American journal of physiology. Cell physiology. 2008, Vol 63, Num 6, issn 0363-6143, C1398-C1406Article

Telomeres and telomerase as targets for anticancer drug developmentOLAUSSEN, Ken André; DUBRANA, Karine; DOMONT, Julien et al.Critical reviews in oncology/hematology. 2006, Vol 57, Num 3, pp 191-214, issn 1040-8428, 24 p.Article

Utility of methyl 2-isothiocyanatobenzoate in the synthesis of some new quinazoline derivatives as potential anticancer and radiosensitizing agentsGHORAB, Mostafa M; RAGAB, Fatma A; HEIBA, Helmi I et al.Arzneimittel-Forschung. 2011, Vol 61, Num 12, issn 0004-4172, E719-E726Article

Nucleoside anticancer drugs: the role of nucleoside transporters in resistance to cancer chemotherapyDAMARAJU, Vijaya L; DAMARAJU, Sambasivarao; YOUNG, James D et al.Oncogene (Basingstoke). 2003, Vol 22, Num 47, pp 7524-7536, issn 0950-9232, 13 p.Article

Interaction with PI3-kinase contributes to the cytotoxic activity of ApoptinMADDIKA, S; WIECHEC, E; ANDE, S. R et al.Oncogene (Basingstoke). 2008, Vol 27, Num 21, pp 3060-3065, issn 0950-9232, 6 p.Article

Human galectin-3 interacts with two anticancer drugsBOGOEVA, Vanya P; VARRIALE, Antonio; JOHN, Constance M et al.Proteomics (Weinheim. Print). 2010, Vol 10, Num 10, pp 1946-2953, issn 1615-9853, 1008 p.Article

Raman Spectroscopic Imaging for the Real-Time Detection of Chemical Changes Associated with Docetaxel ExposureBRÄUTIGAM, Katharina; BOCKLITZ, Thomas; SCHMITT, Michael et al.ChemPhysChem (Print). 2013, Vol 14, Num 3, pp 550-553, issn 1439-4235, 4 p.Article

Dose banding as an alternative to body surface area-based dosing of chemotherapeutic agentsCHATELUT, E; WHITE-KONING, M. L; MATHIJSSEN, Rhj et al.British journal of cancer. 2012, Vol 107, Num 7, pp 1100-1106, issn 0007-0920, 7 p.Article

Cardiac and cardiovascular toxicity of nonanthracycline anticancer drugsJONES, Robin L; EWER, Michael S.Expert review of anticancer therapy. 2006, Vol 6, Num 9, pp 1249-1269, issn 1473-7140, 21 p.Article